Synopsys Inc. (NASDAQ:SNPS) – Equities researchers at DA Davidson issued their Q2 2018 earnings per share estimates for shares of Synopsys in a report issued on Monday. DA Davidson analyst T. Diffely expects that the firm will earn $0.51 per share for the quarter. DA Davidson has a “Buy” rating and a $75.00 price target on the stock. DA Davidson also issued estimates for Synopsys’ Q3 2018 earnings at $0.54 EPS and FY2018 earnings at $2.10 EPS.

A number of other brokerages have also recently commented on SNPS. Zacks Investment Research cut Synopsys from a “buy” rating to a “hold” rating in a research report on Tuesday, August 23rd. Needham & Company LLC upped their price target on Synopsys from $54.00 to $60.00 and gave the company a “buy” rating in a research report on Thursday, August 18th. KeyCorp upped their price target on Synopsys from $60.00 to $64.00 and gave the company an “overweight” rating in a research report on Thursday, August 18th. Benchmark Co. upped their price target on Synopsys from $50.00 to $60.00 and gave the company a “hold” rating in a research report on Thursday, August 18th. Finally, Pacific Crest upped their price target on Synopsys from $60.00 to $64.00 and gave the company an “overweight” rating in a research report on Thursday, August 18th. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Synopsys currently has an average rating of “Buy” and a consensus target price of $62.38.

Earnings History and Estimates for Synopsys (NASDAQ:SNPS)

Synopsys (NASDAQ:SNPS) traded up 0.45% on Thursday, reaching $59.75. The company’s stock had a trading volume of 899,049 shares. The stock’s 50 day moving average price is $59.17 and its 200 day moving average price is $53.70. The firm has a market cap of $9.04 billion, a PE ratio of 38.11 and a beta of 0.89. Synopsys has a 52-week low of $39.26 and a 52-week high of $61.36.

Synopsys (NASDAQ:SNPS) last released its earnings results on Wednesday, August 17th. The company reported $0.76 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.74 by $0.02. Synopsys had a return on equity of 12.15% and a net margin of 10.27%. The firm had revenue of $615.20 million for the quarter, compared to analysts’ expectations of $602.89 million. During the same quarter in the previous year, the business posted $0.63 earnings per share. The business’s revenue for the quarter was up 10.7% on a year-over-year basis.

Institutional investors have recently made changes to their positions in the company. Pictet Asset Management Ltd. raised its position in shares of Synopsys by 44.4% in the first quarter. Pictet Asset Management Ltd. now owns 294,597 shares of the company’s stock valued at $13,183,000 after buying an additional 90,547 shares during the period. UBS Asset Management Americas Inc. raised its position in shares of Synopsys by 0.6% in the first quarter. UBS Asset Management Americas Inc. now owns 733,189 shares of the company’s stock valued at $35,515,000 after buying an additional 4,614 shares during the period. Optimum Investment Advisors raised its position in shares of Synopsys by 2.4% in the first quarter. Optimum Investment Advisors now owns 6,500 shares of the company’s stock valued at $315,000 after buying an additional 150 shares during the period. State Street Corp raised its position in shares of Synopsys by 0.6% in the first quarter. State Street Corp now owns 6,111,847 shares of the company’s stock valued at $296,058,000 after buying an additional 34,721 shares during the period. Finally, Zebra Capital Management LLC raised its position in shares of Synopsys by 30.5% in the first quarter. Zebra Capital Management LLC now owns 25,342 shares of the company’s stock valued at $1,228,000 after buying an additional 5,918 shares during the period. Institutional investors and hedge funds own 91.01% of the company’s stock.

In other Synopsys news, Director Alfred Castino sold 10,000 shares of the company’s stock in a transaction dated Monday, September 12th. The stock was sold at an average price of $58.44, for a total value of $584,400.00. Following the transaction, the director now directly owns 27,982 shares in the company, valued at approximately $1,635,268.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Chi-Foon Chan sold 2,000 shares of the company’s stock in a transaction dated Friday, August 19th. The stock was sold at an average price of $58.23, for a total value of $116,460.00. Following the completion of the transaction, the chief executive officer now owns 193,935 shares in the company, valued at $11,292,835.05. The disclosure for this sale can be found here. Corporate insiders own 1.62% of the company’s stock.

Synopsys Company Profile

Synopsys, Inc provides software, intellectual property (IP) and services. The Company supplies the electronic design automation (EDA) software that engineers use to design and test integrated circuits, also known as chips. It also offers IP products, which are pre-designed circuits that engineers use as components of larger chip designs rather than designing those circuits themselves.

5 Day Chart for NASDAQ:SNPS

Receive News & Stock Ratings for Synopsys Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys Inc. and related stocks with our FREE daily email newsletter.